Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway
Main Authors: | Banjun Ruan, Zheng Zhu, Zhao Yan, Wei Yang, Dongsheng Zhai, Li Wang, Zichen Ye, Huanyu Lu, An Xiang, Jingwei Liang, Yinghao Jiang, Chengming Xu, Zhenyu Wang, Ming Wei, Xiaoying Lei, Xiaorui Cao, Zifan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Stem Cell Research & Therapy |
Online Access: | https://doi.org/10.1186/s13287-023-03513-2 |
Similar Items
-
Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway
by: Banjun Ruan, et al.
Published: (2018-03-01) -
cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin.
by: Der-Chih Yang, et al.
Published: (2008-01-01) -
Azoramide ameliorates cadmium-induced cytotoxicity by inhibiting endoplasmic reticulum stress and suppressing oxidative stress
by: Lingmin Zhang, et al.
Published: (2024-01-01) -
Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures.
by: Oreffo, R, et al.
Published: (1997) -
Bone Marrow and Adipose Tissue Adenosine Receptors Effect on Osteogenesis and Adipogenesis
by: Anna Eisenstein, et al.
Published: (2020-10-01)